Search results
Steady Eddie Palo Alto Networks Stock Trades Near High, Gets Rating Upgrade
Investor's Business Daily· 22 hours agoViewing it on a weekly or monthly chart shows Palo Alto Networksstock has risen sharply, in hockey...
Auto stock jumps after company’s board announces IPO of its subsidiary company
Investing.com· 6 days agoOn Thursday, at 11:30 a.m., Hero MotoCorp Ltd shares were trading at ₹5,135 per share, down 0.13...
...Invested $10,000 In NewLake Capital Partners Right After Its IPO, Here's How Much You Would Be...
Benzinga via Yahoo Finance· 4 days agoIt's impossible to predict where a stock's price will go after its initial public offering (IPO)....
Tuesday's analyst calls: Broadcom a top pick, Chinese EV stock to pop more than 30%
CNBC· 8 hours agoPlease refresh every 20-30 minutes to view the latest posts.) Broadcom and a Chinese electric...
Is UiPath Stock a Buy Now?
Motley Fool via Yahoo Finance· 1 day agoBut for now, we can't tell if UiPath is putting on a brave face or actually expects to profit from the secular expansion of the AI market. It isn't cheap...
Shein Plans London IPO with 50 Billion Prospectus Filing Next Week - EconoTimes
EconoTimes· 2 days agoShein, a major fast-fashion company, is preparing to file a prospectus for a £50 billion London IPO...
Life360 Shares Rise as Location App Developer Launches U.S. IPO
Market Watch· 17 hours agoThe IPO price has not been set and will be based on the value of its existing Australia-listed stock, Life360 said. Shares in Life360 were up 1.6% at 15.42 ...
PC Maker Raspberry Pi, Backers Seek £157 Million in Rare UK IPO
Bloomberg via Yahoo Finance· 1 day ago...from BloombergModi Vows to Retain Power Even as Party Loses India MajorityShort Sellers in Danger...
Equity live from SaaStr: The market loses its mind, bitcoin tanks, and when will Slack go public
TechCrunch· 2 hours agoNot only did venture capitalist Annie Lamont join our own Katie Roof, Matthew Lynley, and Alex...
J&J-backed Rapport Therapeutics seeks about $637 mln valuation in US IPO
Reuters· 1 day agoRapport Therapeutics is targeting a valuation of about $637 million in its initial public offering in the United States, as the biopharmaceutical company joins a slew of firms looking to list ...